Mathematical model for cyclocytidine pharmacokinetics.
The pharmacokinetics of the drug cyclocytidine in humans were modeled by using a physiological and anatomical approach. Each pertinent tissue is represented by a single compartment, and these compartments are linked together by the circulatory system. Each compartment is then represented by an ordinary differential equation that represents the rate of change in drug concentration as function of convecting transport, metabolism, and urinary clearance. The models for cyclocytidine and cytarabine are linked together by a hydrolysis term in each equation set. The resulting equation sets are then solved numerically to predict the concentration of both drug species in situ. The models use physiological blood flows, tissue volumes, and clearance parameters. The results of the model show that cyclocytidine can act as a reservoir for cytarabine in vivo over the time studied. This effect is confined to relatively long times and relatively low plasma concentrations.
D003504:Ancitabine / Q000097:blood / Q000378:metabolism*; D003561:Cytarabine / Q000031:analogs & derivatives*; D006801:Humans; D006868:Hydrolysis; D007700:Kinetics; D008954:Models, Biological; D013997:Time Factors
D003561:Cytarabine; D003504:Ancitabine